Effectiveness of high-dose third-generation EGFR-tyrosine kinase inhibitors in treating EGFR-mutated non-small cell lung cancer patients with leptomeningeal metastasis
- Resource Type
- Article
- Source
- In
Lung Cancer February 2024 188 - Subject
- Language
- ISSN
- 0169-5002